These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8800862)

  • 21. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chondroitin sulfate iron colloid as an MR contrast agent for the hepatic reticuloendothelial system.
    Kato T; Suto Y; Matsuo T
    J Comput Assist Tomogr; 1993; 17(4):603-8. PubMed ID: 8392526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
    Petersein J; Saini S; Mitchell DG; Davis PL; Johnson CD; Kuhlman JE; Parisky YR; Runge VM; Weinreb J; Bernardino ME
    AJR Am J Roentgenol; 1995 Nov; 165(5):1157-61. PubMed ID: 7572495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early homogeneously enhancing hemangioma versus hepatocellular carcinoma: differentiation using quantitative analysis of multiphasic dynamic magnetic resonance imaging.
    Jeong MG; Yu JS; Kim KW; Jo BJ; Kim JK
    Yonsei Med J; 1999 Jun; 40(3):248-55. PubMed ID: 10412337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Tomura N; Narita K; Takahashi S; Otani T; Sakuma I; Yasuda K; Nishii T; Watarai J
    Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
    Kim YK; Kwak HS; Kim CS; Han YM
    J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
    Guo T; Zhang XL; Chang RM; Zhang YZ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of multi-echo and single-echo gradient-recalled echo sequences for SPIO-enhanced liver MRI at 3 T.
    Choi JS; Kim MJ; Kim JH; Choi JY; Chung YE; Park MS; Kim KW
    Clin Radiol; 2010 Nov; 65(11):916-23. PubMed ID: 20933647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differentiation between primary hepatocellular carcinoma and hemangioma on MRI].
    Ho YJ; Yang CF; Lee SK; Hung SW; Lee KR
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):92-100. PubMed ID: 1315203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the signal- and contrast-to-noise ratios of hepatocellular carcinomas on gadoxetic acid-enhanced dynamic MR imaging.
    Kim HS; Choi D; Kim SH; Lee MW; Lee WJ; Kim YK; Jang KM; Park MJ; Park CK
    Eur J Radiol; 2013 Jan; 82(1):62-8. PubMed ID: 23079045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.